Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells

M. Kawaguchi, J. Fujita, F. Kokubu, G. Ohara, S. K. Huang, S. Matsukura, Y. Ishii, M. Adachi, H. Satoh, N. Hizawa

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background Increased expression of IL-17F has been noted in the airway of asthmatic patients, but its role in asthma has not been fully elucidated. Insulin-like growth factor-I (IGF-I) is known to be involved in airway remodelling and inflammation, while its regulatory mechanisms remain to be defined. Objective To further clarify the biological function of IL-17F, we investigated whether IL-17F is able to regulate the expression of IGF-I in bronchial epithelial cells. Methods Bronchial epithelial cells were stimulated with IL-17F in the presence or absence of T-helper type 2 cytokines. Various kinase inhibitors were added to the culture to identify the key signalling events leading to the expression of IGF-I, in conjunction with the use of short interfering RNAs (siRNAs) targeting mitogen- and stress-activated protein kinase (MSK) 1, p90 ribosomal S6 kinase (p90RSK), and cyclic AMP response element-binding protein (CREB). Results IL-17F significantly induced IGF-I gene and protein expression, and co-stimulation with IL-4 and IL-13 augmented its production. MAP kinase kinase (MEK) inhibitors and the Raf1 kinase inhibitor significantly inhibited IGF-I production, and the combination of PD98059 and Raf1 kinase inhibitor showed further inhibition. Overexpression of Raf1 and Ras dominant-negative mutants inhibited its expression. MSK1 inhibitors significantly blocked IL17F-induced IGF-I expression. Moreover, transfection of the siRNAs targeting MSK1, p90RSK, and CREB blocked its expression. Conclusions In bronchial epithelial cells, IL-17F is able to induce the expression of IGF-I via the Raf1-MEK1/2-ERK1/2-MSK1/p90RSK-CREB pathway in vitro.

Original languageEnglish
Pages (from-to)1036-1043
Number of pages8
JournalClinical and Experimental Allergy
Volume40
Issue number7
DOIs
Publication statusPublished - Jul 1 2010
Externally publishedYes

Fingerprint

Interleukin-17
Insulin-Like Growth Factor I
Epithelial Cells
90-kDa Ribosomal Protein S6 Kinases
Cyclic AMP Response Element-Binding Protein
Phosphotransferases
Small Interfering RNA
Airway Remodeling
Interleukin-13
Mitogen-Activated Protein Kinase Kinases
Interleukin-4
Transfection
Asthma
Cytokines
Inflammation
Gene Expression

Keywords

  • Bronchial epithelial cell
  • IGF-I
  • IL-17F

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells. / Kawaguchi, M.; Fujita, J.; Kokubu, F.; Ohara, G.; Huang, S. K.; Matsukura, S.; Ishii, Y.; Adachi, M.; Satoh, H.; Hizawa, N.

In: Clinical and Experimental Allergy, Vol. 40, No. 7, 01.07.2010, p. 1036-1043.

Research output: Contribution to journalArticle

Kawaguchi, M, Fujita, J, Kokubu, F, Ohara, G, Huang, SK, Matsukura, S, Ishii, Y, Adachi, M, Satoh, H & Hizawa, N 2010, 'Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells', Clinical and Experimental Allergy, vol. 40, no. 7, pp. 1036-1043. https://doi.org/10.1111/j.1365-2222.2010.03527.x
Kawaguchi, M. ; Fujita, J. ; Kokubu, F. ; Ohara, G. ; Huang, S. K. ; Matsukura, S. ; Ishii, Y. ; Adachi, M. ; Satoh, H. ; Hizawa, N. / Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells. In: Clinical and Experimental Allergy. 2010 ; Vol. 40, No. 7. pp. 1036-1043.
@article{20af25b8da1b4ff4ab99ef5873a74369,
title = "Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells",
abstract = "Background Increased expression of IL-17F has been noted in the airway of asthmatic patients, but its role in asthma has not been fully elucidated. Insulin-like growth factor-I (IGF-I) is known to be involved in airway remodelling and inflammation, while its regulatory mechanisms remain to be defined. Objective To further clarify the biological function of IL-17F, we investigated whether IL-17F is able to regulate the expression of IGF-I in bronchial epithelial cells. Methods Bronchial epithelial cells were stimulated with IL-17F in the presence or absence of T-helper type 2 cytokines. Various kinase inhibitors were added to the culture to identify the key signalling events leading to the expression of IGF-I, in conjunction with the use of short interfering RNAs (siRNAs) targeting mitogen- and stress-activated protein kinase (MSK) 1, p90 ribosomal S6 kinase (p90RSK), and cyclic AMP response element-binding protein (CREB). Results IL-17F significantly induced IGF-I gene and protein expression, and co-stimulation with IL-4 and IL-13 augmented its production. MAP kinase kinase (MEK) inhibitors and the Raf1 kinase inhibitor significantly inhibited IGF-I production, and the combination of PD98059 and Raf1 kinase inhibitor showed further inhibition. Overexpression of Raf1 and Ras dominant-negative mutants inhibited its expression. MSK1 inhibitors significantly blocked IL17F-induced IGF-I expression. Moreover, transfection of the siRNAs targeting MSK1, p90RSK, and CREB blocked its expression. Conclusions In bronchial epithelial cells, IL-17F is able to induce the expression of IGF-I via the Raf1-MEK1/2-ERK1/2-MSK1/p90RSK-CREB pathway in vitro.",
keywords = "Bronchial epithelial cell, IGF-I, IL-17F",
author = "M. Kawaguchi and J. Fujita and F. Kokubu and G. Ohara and Huang, {S. K.} and S. Matsukura and Y. Ishii and M. Adachi and H. Satoh and N. Hizawa",
year = "2010",
month = "7",
day = "1",
doi = "10.1111/j.1365-2222.2010.03527.x",
language = "English",
volume = "40",
pages = "1036--1043",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells

AU - Kawaguchi, M.

AU - Fujita, J.

AU - Kokubu, F.

AU - Ohara, G.

AU - Huang, S. K.

AU - Matsukura, S.

AU - Ishii, Y.

AU - Adachi, M.

AU - Satoh, H.

AU - Hizawa, N.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Background Increased expression of IL-17F has been noted in the airway of asthmatic patients, but its role in asthma has not been fully elucidated. Insulin-like growth factor-I (IGF-I) is known to be involved in airway remodelling and inflammation, while its regulatory mechanisms remain to be defined. Objective To further clarify the biological function of IL-17F, we investigated whether IL-17F is able to regulate the expression of IGF-I in bronchial epithelial cells. Methods Bronchial epithelial cells were stimulated with IL-17F in the presence or absence of T-helper type 2 cytokines. Various kinase inhibitors were added to the culture to identify the key signalling events leading to the expression of IGF-I, in conjunction with the use of short interfering RNAs (siRNAs) targeting mitogen- and stress-activated protein kinase (MSK) 1, p90 ribosomal S6 kinase (p90RSK), and cyclic AMP response element-binding protein (CREB). Results IL-17F significantly induced IGF-I gene and protein expression, and co-stimulation with IL-4 and IL-13 augmented its production. MAP kinase kinase (MEK) inhibitors and the Raf1 kinase inhibitor significantly inhibited IGF-I production, and the combination of PD98059 and Raf1 kinase inhibitor showed further inhibition. Overexpression of Raf1 and Ras dominant-negative mutants inhibited its expression. MSK1 inhibitors significantly blocked IL17F-induced IGF-I expression. Moreover, transfection of the siRNAs targeting MSK1, p90RSK, and CREB blocked its expression. Conclusions In bronchial epithelial cells, IL-17F is able to induce the expression of IGF-I via the Raf1-MEK1/2-ERK1/2-MSK1/p90RSK-CREB pathway in vitro.

AB - Background Increased expression of IL-17F has been noted in the airway of asthmatic patients, but its role in asthma has not been fully elucidated. Insulin-like growth factor-I (IGF-I) is known to be involved in airway remodelling and inflammation, while its regulatory mechanisms remain to be defined. Objective To further clarify the biological function of IL-17F, we investigated whether IL-17F is able to regulate the expression of IGF-I in bronchial epithelial cells. Methods Bronchial epithelial cells were stimulated with IL-17F in the presence or absence of T-helper type 2 cytokines. Various kinase inhibitors were added to the culture to identify the key signalling events leading to the expression of IGF-I, in conjunction with the use of short interfering RNAs (siRNAs) targeting mitogen- and stress-activated protein kinase (MSK) 1, p90 ribosomal S6 kinase (p90RSK), and cyclic AMP response element-binding protein (CREB). Results IL-17F significantly induced IGF-I gene and protein expression, and co-stimulation with IL-4 and IL-13 augmented its production. MAP kinase kinase (MEK) inhibitors and the Raf1 kinase inhibitor significantly inhibited IGF-I production, and the combination of PD98059 and Raf1 kinase inhibitor showed further inhibition. Overexpression of Raf1 and Ras dominant-negative mutants inhibited its expression. MSK1 inhibitors significantly blocked IL17F-induced IGF-I expression. Moreover, transfection of the siRNAs targeting MSK1, p90RSK, and CREB blocked its expression. Conclusions In bronchial epithelial cells, IL-17F is able to induce the expression of IGF-I via the Raf1-MEK1/2-ERK1/2-MSK1/p90RSK-CREB pathway in vitro.

KW - Bronchial epithelial cell

KW - IGF-I

KW - IL-17F

UR - http://www.scopus.com/inward/record.url?scp=77953519945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953519945&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2222.2010.03527.x

DO - 10.1111/j.1365-2222.2010.03527.x

M3 - Article

C2 - 20642578

AN - SCOPUS:77953519945

VL - 40

SP - 1036

EP - 1043

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 7

ER -